Insider Trading History of Aunins John G.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Aunins John G. since 2016. The trader's CIK number is 1643756. At the time of the last reporting, Aunins John G. was the Chief Technology Officer & EVP of Seres Therapeutics, Inc.. (stock ticker symbol MCRB). Also see all insider trading activities at Seres Therapeutics, Inc..


Yearly summary of insider trading at Seres Therapeutics, Inc. (MCRB) by Aunins John G.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 MCRB 0 $0 0 $0 12,500 $0
2019 MCRB 0 $0 0 $0 7,500 $0
2018 MCRB 0 $0 130,252 $986,854 20,000 $0
2017 MCRB 0 $0 1,623 $16,457 5,000 $0
2016 MCRB 0 $0 79,465 $2,246,730 187,500 $90,000


Insider trading of Seres Therapeutics, Inc. (MCRB) by Aunins John G.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-01-26 MCRB Option Ex 12,500 .00 0
2019-01-26 MCRB Option Ex 7,500 .00 0
2018-12-17 MCRB Sale 14,282 6.39 91,319
2018-12-19 MCRB Option Ex 10,000 .00 0
2018-11-15 MCRB Sale 14,279 8.26 117,915
2018-10-15 MCRB Sale 14,279 5.94 84,802
2018-08-15 MCRB Sale 14,279 7.57 108,063
2018-09-17 MCRB Sale 14,279 7.28 103,879
2018-05-15 MCRB Sale 14,279 8.08 115,402
2018-07-15 MCRB Sale 14,279 8.11 115,731
2018-06-19 MCRB Option Ex 5,000 .00 0
2018-06-15 MCRB Sale 14,279 8.57 122,328
2018-04-25 MCRB Sale 14,279 7.58 108,263
2018-01-26 MCRB Option Ex 5,000 .00 0
2018-01-26 MCRB Sale 1,738 11.02 19,152
2017-12-19 MCRB Option Ex 5,000 .00 0
2017-12-19 MCRB Sale 1,623 10.14 16,457
2016-08-29 MCRB Sale 9,390 10.87 102,069
2016-07-27 MCRB Sale 9,250 35.00 323,750
2016-07-25 MCRB Sale 9,390 34.18 320,950
2016-07-22 MCRB Option Ex 187,500 .48 90,000
2016-06-27 MCRB Sale 9,390 27.23 255,689
2016-05-31 MCRB Sale 14,015 30.30 424,584
2016-04-25 MCRB Sale 18,640 31.94 595,361
2016-03-28 MCRB Sale 9,390 23.89 224,327

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aunins John G. (Chief Technology Officer & EVP of Seres Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.